Australian drugs regulator cancels registration of COX 2 inhibitor
AUTOR(ES)
Burton, Bob
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1952527Documentos Relacionados
- Agencies “failed miserably” over COX 2 inhibitor
- Agencies "failed miserably" over COX-2 inhibitor
- Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
- Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors
- COX 2 inhibitor rejected in North America but retained in Europe